Wang X - Search Results

1

The application of oncolytic viruses in cancer therapy.

Gao Y, Wu Y, Huan T, Wang X, Xu J, Xu Q, Yu F, Shi H. Gao Y, et al. Among authors: wang x. Biotechnol Lett. 2021 Oct;43(10):1945-1954. doi: 10.1007/s10529-021-03173-3. Epub 2021 Aug 26. Biotechnol Lett. 2021. PMID: 34448096 Review.

2

Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer.

Yu F, Wang X, Shi H, Jiang M, Xu J, Sun M, Xu Q, Addai FP, Shi H, Gu J, Zhou Y, Liu L. Yu F, et al. Among authors: wang x. Tumori. 2021 Aug;107(4):341-352. doi: 10.1177/0300891620960223. Epub 2020 Sep 28. Tumori. 2021. PMID: 32988314

3

Activation-induced cell death in CAR-T cell therapy.

Huan T, Chen D, Liu G, Zhang H, Wang X, Wu Z, Wu Y, Xu Q, Yu F. Huan T, et al. Among authors: wang x. Hum Cell. 2022 Mar;35(2):441-447. doi: 10.1007/s13577-022-00670-z. Epub 2022 Jan 15. Hum Cell. 2022. PMID: 35032297 Review.

4

Application of Elastin-like Polypeptide in Tumor Therapy.

Shi X, Chen D, Liu G, Zhang H, Wang X, Wu Z, Wu Y, Yu F, Xu Q. Shi X, et al. Among authors: wang x. Cancers (Basel). 2022 Jul 28;14(15):3683. doi: 10.3390/cancers14153683. Cancers (Basel). 2022. PMID: 35954346 Free PMC article. Review.

5

Cell Adhesion Molecule CD99 in Cancer Immunotherapy.

Yu F, Liu G, Zhang H, Wang X, Wu Z, Xu Q, Wu Y, Chen D. Yu F, et al. Among authors: wang x. Curr Mol Med. 2023;23(10):1028-1036. doi: 10.2174/1566524023666221007143513. Curr Mol Med. 2023. PMID: 36214301 Review.

6

Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells.

Yu F, Gao Y, Wu Y, Dai A, Wang X, Zhang X, Liu G, Xu Q, Chen D. Yu F, et al. Among authors: wang x. Cancers (Basel). 2022 Oct 9;14(19):4947. doi: 10.3390/cancers14194947. Cancers (Basel). 2022. PMID: 36230871 Free PMC article.

7

Transcription factors in chimeric antigen receptor T-cell development.

Dai A, Zhang X, Wang X, Liu G, Wang Q, Yu F. Dai A, et al. Among authors: wang x, wang q. Hum Cell. 2024 May;37(3):571-581. doi: 10.1007/s13577-024-01040-7. Epub 2024 Mar 4. Hum Cell. 2024. PMID: 38436882 Review.

8

Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor.

Wang X, Liu G, Shi X, Wang Y, Jiang B, Liu W, Dai A, Zhang X, Yu F. Wang X, et al. Among authors: wang y. Hum Cell. 2024 Jul;37(4):1107-1119. doi: 10.1007/s13577-024-01066-x. Epub 2024 May 1. Hum Cell. 2024. PMID: 38691335

9

Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting.

Wang X, Liu G, Huan T, Wang Y, Jiang B, Liu W, Dai A, Zhang X, Yu F. Wang X, et al. Among authors: wang y. Hum Cell. 2024 Sep;37(5):1421-1433. doi: 10.1007/s13577-024-01088-5. Epub 2024 Jun 15. Hum Cell. 2024. PMID: 38878230

10

The efficacy and safety of bevacizumab combined with FOLFOX regimen in the treatment of advanced colorectal cancer: A systematic review and meta-analysis.

Zhang H, You J, Liu W, Chen D, Zhang S, Wang X. Zhang H, et al. Among authors: wang x. Medicine (Baltimore). 2021 Jul 30;100(30):e26714. doi: 10.1097/MD.0000000000026714. Medicine (Baltimore). 2021. PMID: 34397704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206,690 results

Search Page

Filters